The ROW Foundation has surpassed the $2 million mark in medication grants to alleviate the suffering caused by epilepsy around the world. As a result, thousands of people in places like Sierra Leone, Haiti, Armenia, Bolivia, and Venezuela have new hope for a brighter future. And we’re just getting started!
Pushing us past this milestone are two recent grants, including one of 676 cases of Roweepra® —wholesale value, $1.6 million—to a large and well-established international partner that distributes medications through a network of clinics in under-resourced communities throughout Africa, India, the Philippines, and many other countries.
A second grant went to Venezuela, which is currently experiencing a severe shortage of medicines that makes it very difficult for people to get essential medical care. The Pharmaceutical Federation of Venezuela estimates 85 percent of medicines are not available, and states “the entire Venezuelan health care system is on the verge of collapse.” Anti-epileptic drugs are amongst the hardest to find.
Through the generosity of OWP, ROW granted 125 cases of Roweepra—wholesale value, $300,000—as emergency humanitarian aid to the Cuatro por Venezuela Foundation and the Venezuelan chapter of the International League Against Epilepsy (LIVECE). Dr. Beatriz Gonzalez, LIVECE president, estimates that this quantity of Roweepra will provide immediate treatment for at least 1,000 patients.
We won’t always be able to hit home runs like this, but every month we will do something to help those with epilepsy and associated psychiatric disorders get off the sidelines and into the game of life. Learn how you can join us at, https://www.rowpharma.org.
“I’m disturbed by a world of ‘haves’ with access to life-saving treatments who withhold them from the ‘have nots’ simply because they lack resources. We will fight this medical injustice by working to make effective treatments available to all people, at all times, in all places.”
–Scott Boyer, Founder, ROW Foundation